4//SEC Filing
Smith Kevin Raymond Merrill 4
Accession 0001493152-20-010502
CIK 0001444307other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 9:07 PM ET
Size
5.6 KB
Accession
0001493152-20-010502
Insider Transaction Report
Form 4
Smith Kevin Raymond Merrill
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-05-29+25,000→ 25,000 totalExercise: $1.56From: 2020-04-14Exp: 2030-04-14→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The option grant was approved by the Issuer's Compensation Committee on April 14, 2020, subject to stockholder approval of an amendment to the Issuer's 2011 Incentive Plan to increase the number of authorized shares. The Issuer's stockholders approved the plan amendment on May 29, 2020.
- [F2]The option vests quarterly over the next three years.
Documents
Issuer
ONCOSEC MEDICAL Inc
CIK 0001444307
Entity typeother
Related Parties
1- filerCIK 0001802639
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 9:07 PM ET
- Size
- 5.6 KB